cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Accelerate Diagnostics Inc
14 own
39 watching
Current Price
$0
$0.05
(7.13%)
logo-axdx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
65.98M
52-Week High
52-Week High
3.737
52-Week Low
52-Week Low
0.4642
Average Volume
Average Volume
0.17M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
23.1926
iconMarket Capitalization65.98M
icon52-Week High3.737
icon52-Week Low0.4642
iconAverage Volume0.17M
iconDividend Yield--
iconP/E Ratio23.1926
What does the Accelerate Diagnostics Inc do?
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States. It offers Accelerate Pheno system, an vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.
Read More
How much money does Accelerate Diagnostics Inc make?
News & Events about Accelerate Diagnostics Inc.
Zolmax
12days ago
StockNews.com lowered shares of Accelerate Diagnostics (NASDAQ:AXDX Get Rating) from a hold rating to a sell rating in a research note issued to investors on Wednesday morning. Accelerate Diagnostics Trading Down 3.7 % Shares of NASDAQ AXDX opened at $0.70 on Wednesday. The firm has a market cap of...
Globe Newswire
2 months ago
NEW YORK, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Accelerate Diagnostics, Inc. (NASDAQ: AXDX), and Veru Inc. (NASDAQ: VERU). Our investigations concern whether these companies have ...
Globe Newswire
2 months ago
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Establishment Labs Holdings Inc. (NASDAQ: ESTA), Accelerate Diagnostics, Inc. (NASDAQ: AXDX), Instil Bio, Inc. (NASDAQ: TIL), and ...
Globe Newswire
2 months ago
NEW YORK, Nov. 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Accelerate Diagnostics, Inc. (NASDAQ: AXDX), and Instil Bio, Inc. (NASDAQ: TIL). Our investigations concern whether these companies ...
PR Newswire
3 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDX PR Newswire NEW YORK, Nov. 4, 2022 NEW YORK, Nov. 4, 2022...
Frequently Asked Questions
Frequently Asked Questions
What is Accelerate Diagnostics Inc share price today?
plus_minus_icon
Can Indians buy Accelerate Diagnostics Inc shares?
plus_minus_icon
How can I buy Accelerate Diagnostics Inc shares from India?
plus_minus_icon
Can Fractional shares of Accelerate Diagnostics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Accelerate Diagnostics Inc stocks?
plus_minus_icon
What is today’s traded volume of Accelerate Diagnostics Inc?
plus_minus_icon
What is today’s market capitalisation of Accelerate Diagnostics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Accelerate Diagnostics Inc?
plus_minus_icon
What percentage is Accelerate Diagnostics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Accelerate Diagnostics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.05
(7.13%)
logo-axdx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
ORCHARD THERAPEUTICS PLC
ORCHARD THERAPEUTICS PLC
$0.57
$0.00 (-0.84 %)
Cardiff Oncology Inc
Cardiff Oncology Inc
$1.72
$0.01 (0.58 %)
Mesoblast
Mesoblast
$3.64
$0.04 (1.25 %)
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
$1.82
$0.15 (8.98 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
ORCHARD THERAPEUTICS PLC
ORCHARD THERAPEUTICS PLC
$0.57
$0.00 (-0.84 %)
Cardiff Oncology Inc
Cardiff Oncology Inc
$1.72
$0.01 (0.58 %)
Mesoblast
Mesoblast
$3.64
$0.04 (1.25 %)
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
$1.82
$0.15 (8.98 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00